Gressier L, Pruvost-Balland C, Dubertret L, Viguier M
Service de dermatologie, hôpital Saint-Louis, université Denis-Diderot Paris-VII, 1, avenue Claude-Vellefaux, 75475 Paris cedex 10, France.
Ann Dermatol Venereol. 2009 Jan;136(1):50-3. doi: 10.1016/j.annder.2008.07.063. Epub 2008 Nov 28.
Atorvastatin is a widely-used therapeutic statin given for hypercholesterolaemia and for prevention of cardiovascular events. We report herein the occurrence of a drug reaction with eosinophilia and systemic symptoms (DRESS) secondary to intake of this drug.
A 58-year-old woman presented with a febrile skin rash and facial oedema, appearing 6weeks after the start of atorvastatin for dyslipidaemia. The clinical features associated disseminated polymorphic lesions, oral mucosa involvement and systemic symptoms (fever, abdominal pain, diarrhoea, polyarthralgia and adenomegaly). Blood tests showed hypereosinophilia up to 11,540/mm(3), inflammatory syndrome and anicteric cholestasis without cytolysis. Serological tests for hepatitis B and C, HIV, EBV, HHV-6, HHV-8, CMV and human Parvovirus B-19 were negative. Cutaneous histology was unspecific. A diagnosis of DRESS secondary to atorvastatin was suspected. The clinical outcome was favourable after atorvastatin discontinuation.
To our knowledge, this is the first description of atorvastatin inducing DRESS, a severe life-threatening drug eruption. Atorvastatin has previously been implicated in various cutaneous adverse events. Because of their potentially serious side effects, prescription of statins must be carefully evaluated.
阿托伐他汀是一种广泛用于治疗高胆固醇血症和预防心血管事件的他汀类药物。我们在此报告服用该药物后发生的伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)。
一名58岁女性,因血脂异常开始服用阿托伐他汀6周后出现发热性皮疹和面部水肿。临床特征包括弥漫性多形性损害、口腔黏膜受累及全身症状(发热、腹痛、腹泻、多关节痛和淋巴结肿大)。血液检查显示嗜酸性粒细胞增多高达11,540/mm³、炎症综合征和无细胞溶解的无黄疸型胆汁淤积。乙肝、丙肝、HIV、EBV、HHV - 6、HHV - 8、CMV和人细小病毒B19的血清学检查均为阴性。皮肤组织学检查无特异性。怀疑为阿托伐他汀继发的DRESS。停用阿托伐他汀后临床结局良好。
据我们所知,这是阿托伐他汀诱发DRESS(一种严重的危及生命的药疹)的首次描述。阿托伐他汀此前曾与多种皮肤不良事件有关。由于他汀类药物可能存在严重的副作用,其处方必须仔细评估。